Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-09

Clinical Trial Update: Impact of Low Protein Diet Supplemented With Ketoanalogues Supplementation on Uremic Toxins Production [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating low protein diet with ketoanalogues supplementation and its effect on uremic toxin production in renal failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ketoanalogues supplementation

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Renal Failure | Phase 3 | Status: UNKNOWN